Share price: 112.80p

AGM Statement

10th May 2016

Cello Group plc (AIM:CLL), the pharmaceutical and consumer strategic marketing group, announces that at the Annual General Meeting this afternoon, Chairman Allan Rich will say:

“The Group has had a good start to the year in both Cello Health and Cello Signal, in line with expectations.

Cello Health (www.cellohealth.com) has experienced a good start to the year, particularly in the Insight and Communications capabilities in both the UK and the US. Several significant new mandates have been secured in these businesses and, combined with successful collaboration between all of the capabilities in Cello Health, the overall income pipeline is robust. Performance in one component of Cello Health Consumer remains slow.

Cello Signal (www.cellosignal.com) has also had a good start to the year, with new and extended client relationships making a positive impact, particularly in Scotland and Cheltenham. Pulsar continues to show strong growth and is now trading profitably.

Progress has been made on the VAT dispute with HMRC as the Group continues to work towards reaching a final settlement.

The Board continues to be confident of a successful full year for 2016.”

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150